First Time Loading...

Pacira Biosciences Inc
NASDAQ:PCRX

Watchlist Manager
Pacira Biosciences Inc Logo
Pacira Biosciences Inc
NASDAQ:PCRX
Watchlist
Price: 26.985 USD -0.83% Market Closed
Updated: May 6, 2024

Pacira Biosciences Inc
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Pacira Biosciences Inc
Net Income (Common) Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Pacira Biosciences Inc
NASDAQ:PCRX
Net Income (Common)
$42m
CAGR 3-Years
-34%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Net Income (Common)
$38.5B
CAGR 3-Years
37%
CAGR 5-Years
21%
CAGR 10-Years
10%
Bristol-Myers Squibb Co
NYSE:BMY
Net Income (Common)
-$6.1B
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pfizer Inc
NYSE:PFE
Net Income (Common)
-$309m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
Net Income (Common)
$2.3B
CAGR 3-Years
-31%
CAGR 5-Years
-23%
CAGR 10-Years
-7%
Eli Lilly and Co
NYSE:LLY
Net Income (Common)
$6.1B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
5%

See Also

What is Pacira Biosciences Inc's Net Income (Common)?
Net Income (Common)
42m USD

Based on the financial report for Dec 31, 2023, Pacira Biosciences Inc's Net Income (Common) amounts to 42m USD.

What is Pacira Biosciences Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 3Y
-34%

Over the last year, the Net Income (Common) growth was 164%. The average annual Net Income (Common) growth rates for Pacira Biosciences Inc have been -34% over the past three years .